Earnings History Data for Cytosorbents Corporation (CTSO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Cytosorbents Corporation

CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
02-08-2022 AH 4:15 PM ET
(Aug 2)		 CTSO Cytosorbents Corporation 92.79 -0.25 -0.14 -0.11 Cytosorbents GAAP EPS of -$0.25 misses by $0.13, revenue of $8.5M misses by $1.06M
[8/2/2022 4:44 PM]		 2.00 -0.33 
(-14.32%)		 2.32 -0.02 
(-0.85%)		 1.69 - 9.80 347,477 60,000 225
03-05-2022 AH 4:15 PM ET
(May 3)		 CTSO Cytosorbents 89.00 -0.21 -0.15 0.00 Cytosorbents GAAP EPS of -$0.21 misses by $0.06, revenue of $8.69M misses by $1.32M
[5/3/2022 4:35 PM]		 2.11 -0.07 
(-3.21%)		 1.98 -0.20 
(-9.17%)		 1.80 - 9.80 507,584 290,000 22,287
08-03-2022 AH 4:15 PM ET
(Mar 8)		 CTSO Cytosorbents Corporation 168.69 -0.21 -0.13 0.00 Cytosorbents reports Q4 results
[3/8/2022 4:37 PM]		 3.37 -0.38 
(-10.13%)		 3.60 -0.15 
(-4.00%)		 3.18 - 9.80 148,854 150,000 24,470
04-11-2021 AH 4:15 PM ET
(Nov 4)		 CTSO Cytosorbents Corporation 252.47 -0.15 -0.11 -0.02 Cytosorbents EPS misses by $0.03, beats on revenue
[11/4/2021 4:29 PM]		 6.25 0.14 
(2.29%)		 6.25 0.14 
(2.29%)		 5.73 - 11.68 314,316 180,000 1,442
03-08-2021 AH 4:15 PM ET
(Aug 3)		 CTSO Cytosorbents Corporation 328.43 -0.11 -0.03 -0.08 Cytosorbents EPS misses by $0.06, beats on revenue
[8/3/2021 4:35 PM]		 7.01 -0.24 
(-3.37%)		 7.30 0.04 
(0.55%)		 7.01 - 11.68 211,509 150,000 388
04-05-2021 AH 4:15 PM ET
(May 4)		 CTSO Cytosorbents Corporation 392.74 -0.10 -0.03 -0.10 Cytosorbents EPS misses by $0.05, misses on revenue
[5/4/2021 4:33 PM]		 8.70 -0.39 
(-4.29%)		 8.50 -0.59 
(-6.49%)		 7.13 - 11.74 450,129 220,000 7,639
09-03-2021 AH 4:15 PM ET
(Mar 9)		 CTSO Cytosorbents Corporation 370.29 N/A -0.04 -0.13 Cytosorbents EPS beats by $0.03, beats on revenue
[3/9/2021 4:21 PM]		 8.56 -0.19 
(-2.17%)		 9.15 0.40 
(4.57%)		 3.60 - 11.74 306,589 296,352 259
04-11-2020 AH 4:15 PM ET
(Nov 4)		 CTSO Cytosorbents Corporation 346.99 -0.02 -0.09 -0.21 Cytosorbents EPS beats by $0.07, beats on revenue
[11/4/2020 4:23 PM]		 8.92 0.53 
(6.32%)		 8.90 0.51 
(6.08%)		 3.49 - 11.74 460,890 282,170 5,325
04-08-2020 AH 4:15 PM ET
(Aug 4)		 CTSO Cytosorbents Corporation 411.47 -0.08 -0.08 -0.11 Cytosorbents EPS in-line, misses on revenue
[8/4/2020 4:33 PM]		 9.94 0.53 
(5.63%)		 9.30 -0.11 
(-1.17%)		 3.49 - 11.74 425,265 1,012,793 139
05-05-2020 AH 4:15 PM ET
(May 5)		 CTSO Cytosorbents Corporation 311.42 -0.10 -0.14 -0.15 Cytosorbents EPS beats by $0.05, beats on revenue
[5/5/2020 4:19 PM]		 9.31 -0.07 
(-0.75%)		 10.10 0.79 
(8.49%)		 3.49 - 10.24 471,069 835,146 9,333